Bio-Rad Laboratories
BIO
$367.76+1.47%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
N/A
EV/Sales
N/A
P/E ratio
44.8
FY2025 Revenue
$2.58B
EPS (TTM)
$8.21
Gross Margin (FY2025)
51.87%
Profit Margin (FY2025)
29.42%
Beta
N/A
Div yield
N/A
Sector
N/A
No recent filings in cache.
Bio-Rad Laboratories (BIO) common stock.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. BIO currently screens at trailing P/E 44.8.
Use this BIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BIO income, balance, and cash tables.
Latest cached Bio-Rad Laboratories (BIO) revenue for Dec 31, 2025 was $2.58B. Net income was $759.9M. Statements: https://lician.com/financials/bio
Bio-Rad Laboratories (BIO) trailing P/E is 44.8 on the latest cached fundamentals snapshot.
Bio-Rad Laboratories (BIO) cached previous close $362.43; day range $364.90 – $367.76; volume 113,731. Session quote: https://lician.com/quote/bio
Bio-Rad Laboratories (BIO) latest cached earnings event is "BIO earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings